Tag: Prostate Cancer
11 July 2021
Report: Plenary session 5 explores mHSPC treatments
The role of novel imaging and the treatment options for metastatic hormone-sensitive prostate cancer (mHSPC) were some of the topics
10 July 2021
Risk stratification and artificial intelligence in MRI-based early detection of prostate cancer
By: Dr. Maarten De Rooij (Nijmegen, NL), Department of Medical Imaging at Radboud university medical centre Prof. Hein Van Poppel (Leuven,
09 July 2021
Report: Nightmare session on early detection of prostate cancer
One of the highlights of the Annual EAU Congress is the Nightmare session. At EAU21 Virtual, too, the Nightmare session
07 July 2021
The PIONEER Big Data platform: How does it apply to prostate cancer?
By Dr. Susan Evans Axelsson (Malmö, SE), Clinical Coordinator PIONEER This article reflects the highlights of the lecture Dr. Susan Evans Axelsson
10 May 2021
PCa: Balancing advantages and disadvantages of early detection
We spoke to Prof. Jochen Walz (Marseille, FR) on how early detection of prostate cancer would be covered at EAU21.
21 February 2018
Key opinion leaders give a glimpse of EAU18 Plenary Sessions (Part 2)
This is part two of three of the recommendations of seven key opinion leaders on the innovative studies to be presented during EAU18’s Plenary Sessions.
24 March 2017